Cataplexy Associated with Narcolepsy
- 145 Downloads
Although narcolepsy was first described over 100 years ago, most of what is known about the pathological changes in the CNS that are responsible for this unusual disease has been learned during the past few years. It is now known that narcolepsy is caused by the loss of a relatively few neurons that are responsible for producing the neuropeptide hypocretin in the CNS. The onset of narcolepsy typically occurs in early adulthood and may consist of a variety of symptoms; however, cataplexy (an abrupt, bilateral loss of skeletal muscle tone) is most specific to narcolepsy.
TCAs were found to be beneficial for the treatment of cataplexy over 40 years ago and, more recently, the SSRIs have been used to treat the condition. The recent availability of sodium oxybate (the first drug to receive regulatory approval for the treatment of cataplexy) represents a significant advance in the treatment of narcolepsy, as it is highly efficacious for the treatment of cataplexy and shows promise for the treatment of excessive sleepiness and for improving sleep quality in patients with narcolepsy.
KeywordsSelegiline Excessive Daytime Sleepiness Narcolepsy Reboxetine Sodium Oxybate
The help and assistance of Carl Hornfeldt of Orphan Medical Inc. in the preparation of this manuscript is appreciated by the author. Dr Thorpy is on the Speakers Bureau for Orphan Medical Inc. No sources of funding were used to assist in the preparation of this review.
- 14.Passouant P, Billiard M. The evolution of narcolepsy with age. In: Guilleminault C, Dement WC, Passouant P, editors. Narcolepsy. New York: Spectrum, 1976: 179–96Google Scholar
- 40.US Xyrem® Multicenter Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 2002; 25: 42–9Google Scholar
- 47.Xyrem® International Study Group. A double-blind, placebo-controlled study demonstrates the nightly administration of sodium oxybate significantly improves excessive daytime sleepiness in narcolepsy patients taking concurrent stimulant medications. J Clin Sleep Med 2005; 1: 391–7Google Scholar
- 55.Smith M, Parkes JD, Dahlitz M. Venlafaxine in the treatment of the narcoleptic syndrome. J Sleep Res 1996; 5Suppl. 1: 217Google Scholar